CA-17112: PROSPECTIVE EUROPEAN DRUG-INDUCED LIVER INJURY NETWORK

The Consensus Conference on drug-induced autoimmune hepatitis (DI-AIH) will take place on 2-3 March 2022, at the Parador de Nerja in Malaga (Spain).

The main objective of the international working group meeting on DILI is to reach a consensus on liver toxicity with manifestations of autoimmunity.

CA-17112: Prospective European Drug-Induced Liver Injury Network (Pro Euro DILI Network), involves cohort of DILI patients with biological samples from the UK, Spain, Portugal, Germany, Iceland, France, Italy and Switzerland brought together by a web-based data base held in Malaga and a biobank based in Nottingham. Building on from this, we have developed a multidisciplinary network of over 60 top European experts coming from 28 countries,  Prospective European Drug-induced Liver Injury Network’ with the grant that we secured in 2017 from the European Cooperation in Science & Technology (COST ACTION 17_112).

NOTE: This event is exclusive to the members of the CA-17112: Prospective European Drug-Induced Liver Injury Network. Registration includes access to the virtual event only.

More information on the official website.